Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;43(1):21-30.
doi: 10.1007/s40618-019-01087-6. Epub 2019 Jul 31.

Copeptin in the differential diagnosis of hypotonic polyuria

Affiliations
Review

Copeptin in the differential diagnosis of hypotonic polyuria

M Christ-Crain et al. J Endocrinol Invest. 2020 Jan.

Abstract

Copeptin: Copeptin is secreted in equimolar amount to Arginine Vasopressin (AVP) but can easily be measured with a sandwich immunoassay. Both peptides, copeptin and AVP, show a high correlation. Accordingly, copeptin mirrors the amount of AVP in the circulation and its measurement provides an attractive marker in the differential diagnosis of diabetes insipidus.

The polyuria polydipsia syndrome: Diabetes insipidus-either central or nephrogenic-has to be differentiated from primary polydipsia. Differentiation is crucial since wrong treatment can have deleterious consequences. Since many decades, the "gold standard" for differential diagnosis has been the classical water deprivation test, which has several limitations leading to an overall limited diagnostic accuracy. In addition, the test has a long duration of 17 hours and is cumbersome for patients. Clinical signs and symptoms as well as MRI characteristics overlap between patients with diabetes insipidus and primary polydipsia. Direct measurement of AVP upon osmotic stimulation was first shown to overcome these limitations, but failed to enter clinical practice mainly due to technical limitations of the AVP assay.

Copeptin as diagnostic tool in the polyuria polydipsia syndrome: We have recently shown that copeptin, without prior water deprivation, identifies patients with nephrogenic diabetes insipidus. On the other hand, for the more difficult differentiation between central diabetes insipidus and primary polydipsia, a copeptin level of 4.9 pmol/L stimulated with hypertonic saline infusion differentiates between these two entities with a high diagnostic accuracy, and is superior to the water deprivation test. It is important to note that close sodium monitoring during the hypertonic saline test is a prerequisite.

Conclusion: Therefore, we propose that copeptin upon hypertonic saline infusion should become the new standard test in the differential diagnosis of diabetes insipidus.

Keywords: Diabetes insipidus; Differential diagnosis; Primary polydipsia.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Biochem Biophys Res Commun. 1988 Feb 29;151(1):524-9 - PubMed
    1. J Clin Endocrinol Metab. 2015 Jun;100(6):2268-74 - PubMed
    1. Acta Endocrinol (Copenh). 1983 Dec;104(4):410-6 - PubMed
    1. J Comput Assist Tomogr. 1987 Mar-Apr;11(2):221-5 - PubMed
    1. J Clin Endocrinol Metab. 1947 Nov;7(11):753-66 - PubMed

LinkOut - more resources